The corporate stopped scientific trials early as a result of preliminary outcomes for the drug had been so optimistic.
Covid: Pfizer says antiviral capsule 89% efficient in excessive threat instances
The corporate stopped scientific trials early as a result of preliminary outcomes for the drug had been so optimistic.